Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
No entries.
Section 2 · machine-generated
Variations
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
Other field of use
Coated stent in a flow loop
A benchtop blood compatibility system holds an expandable stent inside a flexible tube with a roughened test section. A coating on the stent carries a direct factor Xa inhibitor and a direct factor IIa inhibitor. A pump circulates blood through the tube while upstream and downstream sampling ports provide samples for measuring inhibitor release and thrombin generation.
Component substitution
Porous polyester sleeve as drug carrier
An electrospun polycaprolactone sleeve replaces a directly applied drug coating on an expandable stent. The sleeve sits on the outer face of the stent lattice and attaches at both ends with polymer sutures. The fibers carry a direct factor Xa inhibitor and a direct factor IIa inhibitor, which diffuse into surrounding fluid as it wets the sleeve.
Separate films for independent release rates
Two polymer films replace a single coating that contains both inhibitors. A hydrated polyethylene glycol film on the inward-facing strut surfaces carries the direct factor IIa inhibitor, and a polycaprolactone film on the outward-facing surfaces carries the direct factor Xa inhibitor. Separate coating passes set the film thicknesses independently, and each film releases its inhibitor by diffusion into fluid on its side of the lattice.
Parameter or scale variation
Three axial bands with graded loading
An 18 mm stent carries three adjacent 6 mm coating bands that span its length. The center band aligns with the injury and contains twice the mass of each inhibitor per unit coated area as either end band. All three bands use the same polymer and nominal dry thickness. Both inhibitors diffuse from each band after fluid wets the coating.
Combination with existing systems
Drug eluting stent on a balloon
A balloon catheter carries an expandable lattice with a direct factor Xa inhibitor and a direct factor IIa inhibitor on its outward-facing strut surfaces. The lattice crimps over the folded balloon between two radiopaque markers. Balloon inflation expands the lattice against the injured segment, and deflation allows catheter withdrawal while the coating releases both inhibitors locally.
Automated or data-driven variant
Vision guided placement of drug droplets
A camera maps the outward-facing struts of a stent mounted on a rotary stage. Software converts the strut map into dispensing coordinates and synchronizes stage rotation with a piezoelectric head that deposits a polymer solution containing both direct inhibitors. A second image locates gaps in the wet coating, and the head deposits additional droplets at those locations before drying.
Cite aspatent.fyi, US 2026/0354994 A1, claim 1, first published 2026-11-19T06:40:31-05:00, https://patent.fyi/US20260354994/, SHA-256 af68dca0fd88951606aa5aac7475377628a7cc83352c0ac19f99148c42990f0d